Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans.
暂无分享,去创建一个
[1] H. Drexler,et al. Physical training improves endothelial function in patients with chronic heart failure. , 1996, Circulation.
[2] H. Drexler,et al. Role of endogenous bradykinin in human coronary vasomotor control. , 1995, Circulation.
[3] W E Haefeli,et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. , 1995, Circulation.
[4] J. Nussberger,et al. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. , 1994, Clinical science.
[5] D. Webb,et al. Local L-NG-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. , 1994, British journal of clinical pharmacology.
[6] J. Ritter,et al. Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist. , 1994, British journal of clinical pharmacology.
[7] R. Busse,et al. Release of nitric oxide by angiotensin‐(1–7) from porcine coronary endothelium: implications for a novel angiotensin receptor , 1994, British journal of pharmacology.
[8] B. Pitt,et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.
[9] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[10] P. Vanhoutte,et al. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. , 1992, Circulation research.
[11] F. Bühler,et al. Blood Pressure Control by the Renin‐Angiotensin System in Normotensive Subjects: Assessment by Angiotensin Converting Enzyme and Renin Inhibition , 1992, Circulation.
[12] P. Vanhoutte,et al. Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries. , 1991, Journal of cardiovascular pharmacology.
[13] R. Busse,et al. Ramiprilat Enhances Endothelial Autacoid Formation by Inhibiting Breakdown of Endothelium‐Derived Bradykinin , 1991, Hypertension.
[14] W. König,et al. Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies , 1991, British journal of pharmacology.
[15] C. Dollery,et al. Effect of vasoactive peptides on prostacyclin synthesis in man , 1986, British journal of pharmacology.